Use of stem cells, conditioning induces immune tolerance

Use of stem cells, conditioning induces immune tolerance

(HealthDay) -- A novel approach using a bioengineered mobilized cellular product enriched with hematopoietic stem cells (HSCs) and tolerogenic graft facilitating cells (FCs) in combination with nonmyeloablative conditioning is safe and practical for inducing immune tolerance after transplantation, according to a study published in the March 7 issue of Science Translational Medicine.

Joseph Leventhal, M.D., from Northwestern Memorial Hospital in Chicago, and colleagues tested an approach to induce in eight individuals, aged 29 to 56 years, receiving human leukocyte antigen-mismatched kidneys and FC/HSC transplants, who underwent conditioning with fludarabine, total body irradiation, and cyclophosphamide. After transplantation, tacrolimus and were used for immunosuppression.

The researchers found that, about one week following transplantation, the absolute neutrophil counts reached a nadir, with recovery by two weeks. At one month, multilineage chimerism ranged from 6 to 100 percent. There was good tolerance of the conditioning, with outpatient management after day two post-surgery. Low-dose tacrolimus monotherapy was given to two patients who exhibited transient chimerism. Two months after transplant, one individual developed viral sepsis and experienced renal artery thrombosis. Durable chimerism, immunocompetence, and donor-specific tolerance were experienced by five subjects, who were successfully weaned off all immunosuppression at one year post-transplant. Anti-donor antibodies were not produced by any of the recipients, nor did any recipient exhibit engraftment syndrome or graft-versus-host-disease.

"These results suggest that manipulation of a mobilized stem cell graft and nonmyeloablative conditioning represents a safe, practical, and reproducible means of inducing durable chimerism and donor-specific tolerance in solid ," the authors write.

Several of the authors disclosed financial ties to Regenerex and/or are authors on a patent pertaining to the study.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Could trophoblasts be the immune cells of pregnancy?

Dec 18, 2014

Trophoblasts, cells that form an outer layer around a fertilized egg and develop into the major part of the placenta, have now been shown to respond to inflammatory danger signals, researchers from Norwegian University of ...

Moms of food-allergic kids need dietician's support

Dec 18, 2014

Discovering your child has a severe food allergy can be a terrible shock. Even more stressful can be determining what foods your child can and cannot eat, and constructing a new diet which might eliminate entire categories ...

Multiple allergic reactions traced to single protein

Dec 17, 2014

Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.